The Lancet Neurology
@TheLancetNeuro
Followers
51,333
Following
430
Media
825
Statuses
7,208
The Lancet Neurology is the leading journal in clinical neurology. We publish articles and reviews that advocate change in, or illuminate, clinical practice.
London, UK
Joined March 2014
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
MOONLIT FLOOR OUT NOW
• 262478 Tweets
JUMP
• 209784 Tweets
Mets
• 163607 Tweets
Falcons
• 66985 Tweets
Baker
• 64425 Tweets
天使の日
• 50895 Tweets
Pete Alonso
• 47049 Tweets
Diana
• 41942 Tweets
Bucs
• 27873 Tweets
Kirk Cousins
• 27492 Tweets
#PowerGhost
• 24940 Tweets
Bijan
• 21801 Tweets
Mooney
• 17983 Tweets
HAVE A SAFE FLIGHT JIN
• 16792 Tweets
Hayırlı Cumalar
• 16229 Tweets
ワートリ
• 15554 Tweets
#PowerBook2Ghost
• 14552 Tweets
Tariq
• 14094 Tweets
感謝マルチガチャ
• 13920 Tweets
Cane
• 13295 Tweets
Bleed
• 11622 Tweets
PRABOWOsiapkan YangTERBAIK
• 11411 Tweets
最大4体ゲット
• 11045 Tweets
人達同士
• 11007 Tweets
KEKUATANkita PERSATUANkita
• 10838 Tweets
Hodge
• 10268 Tweets
Bielsa
• 10053 Tweets
ONLINE FIRST: Mechanisms and clinical implications of small vessel disease
2
153
261
A Rapid Review published in our September issue discusses the post-viral effects of COVID-19 in the olfactory system and their implications
1
127
241
NEW
#COVID19
: Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?
In their Correspondence, Hua Zhao and colleasgues higlight the need to consider potential neurological symptoms of SARS-CoV-2 infection
5
166
223
Neurological associations of COVID-19
5
95
133
Celebrating neuroscience through art: Our covers throughout 2021 will illustrate the extraordinary work of The Cajal Embroidery Project
Read more about Cajal's legacy
1
47
132
Globally,
#stroke
is the second leading cause of death. The GBD 2019 Stroke collaborators call for urgent implementation of effective primary prevention strategies to curb the increasing burden of stroke:
1
70
127
We are 20 years old!
Join us in celebrating two decades of research by reading our special anniversary issue:
4
30
115
The Boston criteria are used worldwide for the in-vivo diagnosis of CAA but have not been updated since 2010. In an Article,
@a_charidimou
and colleagues present updated criteria across the full spectrum of clinical CAA presentations. Read more at:
3
38
99
It's
#MigraineAwarenessWeek
! Brush up with articles & reviews from our
#headache
and
#migraine
collection:
#MindfulofMigraine
0
67
97
“Migraine remains one of the most stigmatised, underfunded, and underrecognised medical conditions”. Read our letter highlighting the
@wfneurology
campaign this
#worldbrainday
to reveal the painful truth about
#migraine
2
74
97
Brain implants have helped a tetraplegic patient to control a whole-body exoskeleton with brain signals in a proof-of-concept demonstration:
1
59
98
In their Review, Professor Nicolaas Bohnen and colleagues provide an update on cholinergic systems and changes in Parkinson's disease and isolated REM sleep behaviour disorder, a Parkinson's disease prodrome.
0
38
93
NEW ISSUE: Read the latest content on chronic cluster headache, myasthenia gravis, cognitive impariment, Parkinson's disease, mitochondrial disease, and more
1
26
87
NEW ISSUE: read the latest content on
#stroke
#ALS
#Spinalmuscularatrophy
#Parkinsons
disease, and more at:
1
25
88
ONLINE FIRST: Weaver and colleagues identify infarct locations most strongly predictive of post stroke cognitive impairment and use this information to develop a prediction model. Read more at:
2
44
87
NEW ISSUE: Read the latest content on Parkinson's disease, seizure prevention in ICH, prognostic biomarkers for TBI, Duchenne muscular dystrophy, MS, tuberous sclerosis complex, and more at:
1
19
81
Our August issue is available online now, including original research on biomarkers in patients with Down syndrome and Alzheimer's disease, outcomes after TBI, and virus-specific T cells for progressive multifocal leukoencephalopathy
3
27
79
NEW ISSUE: Read the latest content on Parkinson's disease, stroke, tauopathies, myasthenia gravis, and epilepsy
0
18
81
NEW! Just published Online First, a Review by Mark Hallett and colleagues on Functional Neurological Disorder.
2
22
82
Physicians should warn their patients of the illusions of pseudomedicine and its risks. Mounting evidence shows that low-cost lifestyle changes are the best interventions to improve brain health and prevent cognitive decline.
2
77
77
NEW ISSUE: Read the latest content on optic neuritis, paediatric MS, Pompe disease, epilepsy, Parkinson's disease, and more at:
0
17
80
NEW! Just published Online First, a phase 3 randomised trial of tenecteplase vs alteplase for acute ischaemic stroke in Norway (NOR-TEST 2 part A)
#ESOC2022
0
40
74
#Migraine
is the most common brain disease, affecting 1 in 7 people worldwide. This year,
#WorldBrainDay
is dedicated to sharing
#thepainfultruth
about migraine
0
49
74
Online now! Rapid Review of timing of
#anticoagulation
after recent ischaemic
#stroke
in patients with atrial fibrillation:
0
47
70
Online now! Part 1 of 3 in our Headache Series: Diagnosis, pathophysiology, and management of cluster headache
#ClusterHeadache
0
48
63
Our September issue is available online now, with content on COVID-19, multiple sclerosis, acute ischaemic stroke, Alzheimer's disease and frontotemporal lobar degeneration, and myelin-oligodendrocyte glycoprotein antibody-associated disease
1
24
64
NEW ISSUE: Read the latest content on insomnia disorder, autosomal dominant Alzheimer's disease, frailty and TBI, autoimmune neuromuscular junction disorders, and more at
0
26
59
Just published Online, The Lancet Neurology Commission on traumatic brain injury
#TBI
Following on from our 2017 TBI Commission, this latest Commission highlights progress and challenges in prevention, clinical care, and research
1
34
58
Stroke is a major cause of death and disability, and its global impact is getting worse. However, it is a highly preventable and treatable condition, meaning the associated health and economic impacts can be substantially reduced.
3
23
59
ONLINE FIRST: Charlotte Teunissen and colleagues review the highly dynamic and accelerating field of blood-based biomarkers for Alzheimer's disease:
@CharlotteTeuni1
1
22
59
ONLINE FIRST: Review of the neurocritical care of tuberculous meningitis
@drjosephdonovan
@ThwaitesGuy
0
30
57
NEW ISSUE: Read the latest content on
#MultipleSclerosis
,
#Migraine
, myotonic dystrophy type 1, cerebral palsy,
#Autism
, carpal tunnel syndrome, MOGAD, and more at
0
18
57
NEW ISSUE: Read the latest content on cervical arterial dissection, lacunar stroke, Friedrich's ataxia, ALS, epilepsy, and more
0
13
56
“The COVID-19 pandemic has revealed the stark reality of neglect of people with dementia, normalised by societies”
2
47
55
Online now! Rapid Review of the glymphatic pathway in neurological disorders by Maiken Nedergaard and colleagues:
0
31
56
NEW ISSUE: Read the latest content on blood pressure management after endovascular therapy; Guillain-Barré syndrome; gene therapy for spinal muscular atrophy;
cerebral microbleeds and prediction of intracranial haemorrhage; and more at
0
13
54
We need a commitment to substantial long-term investment in traumatic brain injury research, see
#TBI
commission
0
56
52
NEW ONLINE: In their Personal View, Brenda Banwell and colleagues propose diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)
1
26
52
NEW ISSUE: Read the latest content, including research on asymptomatic carotid stenosis and risk of stroke, detection of prodromal α-synucleinopathies, and new insights into atypical Alzheimer's disease
1
10
49
ONLINE FIRST:
CSF and blood biomarkers for Parkinson's disease
0
29
51
In a Personal View, Olivier Rascol, Margherita Fabbri, and Werner Poewe discuss the use of amantadine in
#Parkinson
's disease and other movement disorders
0
12
51
Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study
0
29
48
NEW ISSUE: Read the latest content on Duchenne muscular dystrophy, inclusion body myositis, multiple sclerosis, acute brain injury, migraine, stroke, and more at:
1
15
46
Our latest Commission on traumatic brain injury highlights the key areas for future research
#TBI
0
21
44
Today is
#WorldEncephalitisDay
. Find out more about this condition from
@encephalitis
and read this landmark Position Paper in our journal:
#RED4WED
#encephalitis
1
34
44
NEW ISSUE: Read the latest content on unruptured brain arteriovenous malformations, cognitive impairment in type 2 diabetes, Parkinson's disease, stroke, and brain injury after cardiac arrest
1
22
44
ONLINE FIRST: Read the TRUTH trial, comparing two strategies for the treatment of patients with acute ischaemic stroke and increased blood pressure precluding intravenous thrombolysis:
Presented at
#ESOC2024
0
25
47
NEW, published Online First and free to access after registration, a Personal View by Viktor Jirsa and colleagues of the use of personalised virtual brain models in epilepsy.
@HumanBrainProj
@thevirtualbrain
4
15
46
Commission on Traumatic brain injury: integrated approaches to improving prevention, care, & research. Free w/ reg.
2
35
44
Now online from the
@IHME_UW
series on global, regional & national burden of neurological diseases: prevalence, mortality, and disability associated with Alzheimer’s disease and other dementias
#GBDStudy
#openaccess
0
34
45
In their Personal View, Linda Al-Hassany, Peter Goadsby, A H Jan Danser, and Antoinette MaassenVanDenBrink discuss how to optimise migraine treatment for the patient by considering pharmacological aspects of the drugs.
0
13
43
Online now! Review on neuromodulation in the restoration of function after spinal cord injury
#SpinalCordInjury
0
28
43
NEW ISSUE: Read the latest content on narcolepsy in children, ischaemic stroke, basilar artery occlusion, EBV and MS, and family planning considerations in MS at:
1
12
41
"Differences exist between Parkinson's disease in the Western Pacific Region and in Europe and North America that might provide important insights into our understanding of the disease."
Read more at:
#wpc2019
0
28
40
Early evidence of pronounced brain involvement in fatal COVID-19 outcomes
1
35
43
NEW! Just published Online First in The Lancet Neurology, a Series on Optic Neuropathies
1
17
42
NEW ISSUE: Read the latest content on
#stroke
,
#Parkinsonsdisease
, spinal muscular atrophy, optic neuritis, multiple sclerosis, and social determinants of neurological health at:
3
17
42
In our May issue, two Articles report phase 3 data for new drugs for myasthenia gravis. In a linked Comment, Jan Verschuuren discusses how these two new drugs target this neuromuscular disorder, and how they fit within a growing therapeutic landscape.
1
11
41
Online now! Aleksi Sihvonen & colleagues review music-based interventions in neurological
#rehabilitation
(£)
1
42
42
We’ve teamed up with
@TheLancetPsych
to organise a meeting bringing together psychiatry and neurology. Come to Barcelona, Nov 15–17 for the Lancet Summit: Inflammation and Immunity in Disorders of the Brain and Mind.
0
31
41
The genetic architecture of Parkinson's disease
0
21
42
In their Review, Daniel Weintraub and colleagues discuss developments in our inderstanding of the neuropsychiatry of Parkinson's disease, and outline the key unanswered questions and challenges facing this field:
3
14
41
"Increasing clinical and preclinical evidence implicates the microbiome as a possible key susceptibility factor for neurological disorders." Read the latest Review by John Cryan and colleagues:
#MultipleSclerosis
#Parkinsons
#stroke
#alzheimers
#Autism
0
28
42
"The Father is an exceptional cinematic depiction of dementia."
Read Eelco Wijdicks' review of the newly released film The Father:
0
16
40
NEW ISSUE: Read the latest content on
#Downsyndrome
, spinal muscular atrophy, idiopathic hypersomnia,
#AlzheimersDisease
,
#Parkinson
disease, and
#stroke
, as well as our annual Round-up of research across disciplines over the past year
1
16
40
Online now! Global, regional, and national burden of Parkinson’s disease: the first paper in a series from
@IHME_UW
on individual neurological diseases:
#GBDStudy
#Parkinsons
#openaccess
Expert commentary:
0
40
40
New commission: Traumatic brain injury priorities set out how to improve prevention, patient care, & research
#TBI
0
40
39
"Collaboration to improve our knowledge of COVID-19, including its long-term neurological manifestations, must continue to be a high priority"
Read more at:
0
23
39
NEW ONLINE:
@karaannjohnson
,
@MichaelOkun
, and colleagues review the latest evidence on clinical features, diagnosis, genetics, pathophysiology, and treatment of Tourette syndrome
2
16
39
The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial
1
17
39
Online now! 3rd
#TBI
Series paper, paroxysmal sympathetic hyperactivity: the storm after acute brain injury (free)
0
27
38
Today is
#WorldStrokeDay
. Visit our
#stroke
collection for the latest original research, reviews, expert commentary, podcasts and more from across the Lancet family of journals!
#UpAgainAfterStroke
0
22
38
NEW ISSUE: Read the latest content on migraine, multiple sclerosis, Huntington's disease, and more
2
20
39
NEW ISSUE: Read the latest content on
#stroke
, early-onset epilepsy, migraine,
#alzheimersdisease
, and more at:
0
12
37
Menstrual migraine: a distinct disorder needing greater recognition
1
16
37
NEW ISSUE: Read the latest content on
#stroke
, functional neurological disorders, sexual dysfunction in patients with neurological disorders, CDKL5 deficiency disorder, and more at:
1
13
38
Published Online for
#WSC2023
, first results from the COCROACH individual participant data meta-analysis looking at the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage
1
20
37
NEW ISSUE: Read the latest content on intensive versus standard blood pressure control and cognitive function; neuropathological alterations in patients with COVID-19; genetic modifiers of clinical age of onset in Huntington’s disease; and more at:
0
9
37
NEW ISSUE: Read the latest content on asymptomatic carotid artery stenosis, stroke, anti-NMDA receptor encephalitis, migraine, diabetic peripheral neuropathy, sleep disorders, and more at:
1
11
37
NEW ISSUE: Read the latest content on
#migraine
,
#stroke
,
#Huntingtonsdisease
,
#epilepsy
, TBI, autoimmune encephalitis, and more at
1
8
34
NEW ISSUE: Read the latest content on
#migraine
,
#AlzheimersDisease
,
#MultipleSclerosis
,
#DownSyndrome
, intracerebral haemorrhage,
#epilepsy
and more:
0
8
35
NEW ISSUE: Read our latest content on degenerative cervical myelopathy, progressive supranuclear palsy, acute spinal cord injury, focal epilepsy, paediatric
#MultipleSclerosis
, and secondary
#stroke
prevention
1
13
37
The Lancet Summit 2018—Inflammation and Immunity in Disorders of the Brain and Mind
Hosted by
@TheLancetNeuro
and
@TheLancetPsych
, November 15-17, in Barcelona, Spain
Register your interest to attend and submit your abstract by May 18:
#thelancetsummit
0
18
33
Online now! Review of the clinical presentation of stroke-associated cardiac alterations; are these as distinct "stroke–heart syndrome"?
#stroke
#WorldStrokeDay
2
25
36
NEW ONLINE On
#WorldParkinsonsDay
, an Article by
@em_ka_gu
,
@MatthewJFarrer
, and colleagues reports a novel genetic risk factor for Parkinson's disease in the RAB32 gene (Ser71Arg, 213C>G), which was identified in multiple ethnic groups
3
16
36
"The diagnosis of Parkinson's disease has profound implications for patients and their families, and despite important advances, it remains a challenge."
Eduardo Tolosa and colleagues discuss these challenges in their Review:
0
8
35
Presenting now at
#ESOC2019
@ESOstroke
—Effects of antiplatelet therapy on stroke risk by brain imaging features of
#intracerebral
#haemorrhage
and cerebral
#smallvesseldiseases
: subgroup analyses of the RESTART randomised, open-label trial
1
30
36
Call for Posters:
#TheLancetSummit
: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases, Dec 14-16, 2021. Submit your abstracts by Aug 13. . Organised by
@TheLancet
and
@TheLancetNeuro
.
0
20
35
In a Review,
@DavidSeiffge
and colleagues provide an update on secondary stroke prevention in people with atrial fibrillation:
@strokebern
@ash_shoamanesh
@fishingNeurons
@cas_valeria
@UCLstrokeRes
@raberLorenz
1
21
36
This year marks 20 years of TheLancetNeuro. Each issue will celebrate progress in the field since the journal's launch. In our Jan issue, Benjamin Kanter, Christine Lykken, Edvard Moser, and May-Britt Moser reflect on neuroscience in the 21st century:
0
14
35
Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
0
11
36
NEW ISSUE: Read the latest content on
#stroke
, adrenomyeloneuropathy, Tourette syndrome, optic neuropathies, and more at:
1
13
34
In our anniversary issue, we commemorate two decades of progress in neurology. We’d encourage you to explore five landmark papers from our history, and read our Editorial here:
1
11
35
Online now! Review on mechanisms of action for the medium-chain triglyceride
#ketogenic
diet in
#epilepsy
, and other neurological or metabolic disorders.
0
19
32
NEW issue!
Issue highlights:
Transient ischaemic attack and
#stroke
: association with
#dementia
#MultipleSclerosis
: Global Burden of Disease Study 2016 (
@gatesfoundation
)
#Alzheimers
disease dementia: implications of sleep disturbance and inflammation
1
16
33